Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of

Ali Peirovifar1, Manizheh Mostafa Gharehbaghi1, Parvin Mostafa Gharabaghi1

  • 1Neonatal Intensive Care Unit, Al Zahra Hospital, South Arthesh Street, 513866449, Tabriz, Iran. gharehbaghimm@yahoo.com.

Singapore Medical Journal
|December 21, 2013
PubMed

Insights

This study found no significant difference in blood vascular endothelial growth factor (VEGF) or insulin-like growth factor-1 (IGF-1) levels between premature infants with retinopathy of prematurity (ROP) and those without. These findings suggest these specific biomarkers may not be useful indicators for ROP in this age group.

Area of Science:

  • Neonatal Medicine
  • Ophthalmology
  • Biochemistry

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Understanding the biochemical factors involved in ROP is crucial for early detection and intervention.

Purpose of the Study:

  • To investigate the levels of vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1) in premature infants with proliferative ROP.
  • To compare these levels with those in premature infants without ROP.

Main Methods:

  • Blood samples were collected from 71 preterm infants (born ≤32 weeks gestation) 6-8 weeks after birth.
  • Infants were categorized into a control group (no ROP) and a study group (proliferative ROP, stage III+).
  • VEGF and IGF-1 levels were quantified using enzyme-linked immunosorbent assay (ELISA).

Main Results:

  • No significant differences in mean blood IGF-1 levels were observed between the ROP group (18.48 ± 11.79 µg/L) and the control group (16.75 ± 13.74 µg/L).
  • Similarly, mean blood VEGF levels did not differ significantly between the ROP group (267.35 ± 103.43 pg/mL) and the control group (237.52 ± 130.92 pg/mL).
  • Gestational age and postmenstrual age at sampling were comparable between the groups.

Conclusions:

  • Blood IGF-1 and VEGF levels at 6-8 weeks postpartum are not significantly different in premature infants with proliferative ROP compared to those without.
  • These biomarkers may not serve as reliable indicators for diagnosing or assessing the severity of ROP at this stage.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
2.0K